|
市場調査レポート
商品コード
1529407
シーケンサーの世界市場：2023年～2028年Worldwide Sequencer Market, 2023-2028 |
||||||
|
|||||||
| シーケンサーの世界市場：2023年～2028年 |
|
出版日: 2024年08月08日
発行: Kalorama Information
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 目次
当レポートでは、世界のシーケンサー市場について調査し、市場の動向とともに、2023年までの過去データと2028年までの予測データを提供しています。また、市場に参入する企業のプロファイルなど包括的考察を提供しています。
目次
第1章 エグゼクティブサマリー
第2章 市場の発展と動向
- シーケンサー市場は安定しているが変化の兆しあり
- 主要ベンダーのシーケンサーシステムと性能
- お買い得情報
- 動向
- 臨床応用
- 液体生検、循環核酸
- 規制と標準化の取り組み
- 分散化別アクセスの向上
- 競合激化の可能性
- NGS技術の進歩
- ロングリードシーケンス
- 単一細胞シーケンシング
- エピジェネティックシークエンシング
- ハイスループットシーケンシング
- リアルタイムシーケンス
- ポータブルシーケンシングデバイス
- 直接RNAシーケンシング
- 空間トランスクリプトミクス
- メタゲノミクス、マイクロバイオーム
- マルチオミクス統合
第3章 市場分析
- 概要
- シーケンサー市場、製品タイプ別
- シーケンサー市場、国・地域別
- 市場シェア
第4章 企業プロファイル
- 10X Genomics
- Agilent Technologies
- BGI (Beijing Genomics Inst.)
- 出生前検査
- テストサービス
- 全ゲノムシーケンシング（WGS）
- NGSシーケンシング
- コラボレーション
- Berry Genomics
- CareDx
- CareDxが提供する検査サービス
- CareDxが提供する製品
- エレメントバイオサイエンス
- 正確な科学
- 最近の収益と動向
- Illumina
- 診断
- その他のコラボレーションと発表
- 中国
- New England Biolabs
- Oxford Nanopore Technologies
- Pacific Biosciences (PacBio)
- 背景とその他のお知らせ
- Qiagen
- 液体生検
- Revvity
- シーケンシング/ゲノミクス
- 液体生検
- 出産前ビジネス
- ラボサービス
- Singular Genomic
- Takara Bio
- Tecan
- Thermo Fisher Scientific
- 次世代シーケンシング
- 移植医療
- マイクロバイオーム
- その他のコラボレーションと買収
- 遺伝子編集と細胞治療
- ウルティマ・ゲノミクス
Kalorama Information's new comprehensive report, "Worldwide Sequencer Market, 2023-2028", provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.
The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process.
Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.
NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:
- Whole genome sequencing
- Targeted/amplicon resequencing
- Exome sequencing
- SNP analysis
- RNA sequencing
- Gene expression profiling
- Transcriptomics
- Small RNA/miRNA analysis
- ChIP-seq
- Methylation analysis
- Metagenomics
"Worldwide Sequencer Market, 2023-2028" provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.
Kalorama Information's new comprehensive report, Worldwide Sequencer Market, 2023-2028 , provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.
The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process."
Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.
NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:
- Whole genome sequencing
- Targeted/amplicon resequencing
- Exome sequencing
- SNP analysis
- RNA sequencing
- Gene expression profiling
- Transcriptomics
- Small RNA/miRNA analysis
- ChIP-seq
- Methylation analysis
- Metagenomics
Worldwide Sequencer Market, 2023-2028 provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.
Table of Contents
Chapter 1: Executive Summary
- Table 1-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 1-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 1-2: Annual Growth in World Sequencer Market, 2023-2028 (%)
- Table 1-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
- Figure 1-3: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
- Figure 1-4: World Sequencer Market Compound Annual Growth Rate (CAGR), by Product Segment, 2023-2028 (%)
- Table 1-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
- Figure 1-5: World Sequencer Market, Shares by Product Segment, 2023 (%)
- Figure 1-6: Cost of Sequencing a Human Genome, 2001-2023 (in $ millions)
- Current Trends
- Scope and Methodology
- Report Structure
Chapter 2: Market Development and Trends
- Sequencer Market Stable But Poised for Changes
- Major Vendors' Sequencer Systems and Performance
- Table 2-1: Selected Short-Read Sequencer Systems' Performance, 2024
- Table 2-2: Selected Long-Read Sequencer Systems' Performance, 2024
- Deals
- Table 2-3: Deals in Sequencer Market, January 2020-July 2024
- Trends
- Clinical Applications
- Liquid Biopsy, Circulating Nucleic Acids
- Regulatory and Standardization Efforts
- Increased Access Through Decentralization
- Potential for Increasing Competition
- Advancements in NGS Technology
- Long-Read Sequencing
- Single Cell Sequencing
- Epigenetic Sequencing
- High-Throughput Sequencing
- Real-time Sequencing
- Portable Sequencing Devices
- Direct RNA Sequencing
- Spatial Transcriptomics
- Metagenomics, Microbiome
- Multi-Omics Integration
Chapter 3: Market Analysis
- Overview
- Table 3-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 3-1: World Sequencer Market, 2023-2028 (in $ millions)
- Figure 3-2: Illumina Revenue Annual Growth Rate, 2010-2023 (%)
- Figure 3-3: Illumina Revenue Growth Rate 4-Year Moving Average, 2014-2023 (in $ millions)
- Sequencer Market by Product Types
- Table 3-2: World Sequencer Market, by Product Segment, 2023-2028 (in $ millions)
- Table 3-3: World Sequencer Market, Shares by Product Segment, 2023-2028 (%)
- Figure 3-4: World Sequencer Market, Share by Product Segment, 2023 (%)
- Figure 3-5: World Sequencer Market, Share by Product Segment, 2028 (%)
- Sequencer Market by Country and Region
- Table 3-4: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
- Figure 3-6: Geographic Breakout of the World Sequencer Market, by Country/Region (APAC, Europe, North America, Rest of World), 2023 (in $ millions)
- Figure 3-7: Geographic Breakout of the World Sequencer Market, Share by Country/Region (APAC, Europe, North America, Rest of World), 2023 (%)
- Market Shares
- Figure 3-8: World Sequencer Market, by Estimated Market Shares, by Company (Agilent, Illumina, MGI Tech, MilliporeSigma, Oxford Nanopore, Pacific Biosciences, Qiagen, Roche, Thermo Fisher, Other), 2023 (%)
Chapter 4: Company Profiles
- 10X Genomics
- Agilent Technologies
- BGI (Beijing Genomics Inst.)
- Prenatal Testing
- Test Services
- Whole Genome Sequencing (WGS)
- NGS Sequencing
- Collaborations
- Berry Genomics
- CareDx
- Figure 4-1: CareDx Revenue, 2017-Q1 2024 (in $ millions)
- Testing Services Offered by CareDx
- AlloMap Tests
- AlloSure Tests
- Products Offered by CareDx
- Element Biosciences
- Exact Sciences
- Recent Revenues and Developments
- Illumina
- Table 4-1: Illumina's Revenue History, 2015-2023 (in $ millions)
- Figure 4-2: Illumina's Revenue History, 2017-Q1 2024 (in $ millions)
- Diagnostics
- Other Collaborations and Announcements
- China
- New England Biolabs
- Oxford Nanopore Technologies
- Pacific Biosciences (PacBio)
- Background and Other Announcements
- Qiagen
- Liquid Biopsy
- Revvity
- Sequencing/Genomics
- Liquid Biopsy
- Prenatal Business
- Lab Services
- Singular Genomic
- Takara Bio
- Tecan
- Thermo Fisher Scientific
- Next-Generation Sequencing
- Transplant Medicine
- Microbiome
- Other Collaborations and Acquisitions
- Gene Editing and Cell Therapy
- Ultima Genomics
